INKTcells/CD1d regulate intestinal immunity by controlling Treg induction iNKTcells/CD1d regulate intestinal immunity by controlling Treg induction ARegulatory.

Slides:



Advertisements
Similar presentations
Volume 34, Issue 5, Pages (May 2011)
Advertisements

Volume 33, Issue 2, Pages (August 2010)
Volume 40, Issue 4, Pages (April 2014)
Volume 34, Issue 3, Pages (March 2011)
Melanoma donor (MD) NK cells are functionally impaired/exhausted.
Volume 42, Issue 3, Pages (March 2015)
Resveratrol modulates DSS-induced neutrophils during colitis.
Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection
Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway by Kevin M. Elias, Arian Laurence,
Volume 26, Issue 3, Pages (March 2007)
Local Inflammatory Cues Regulate Differentiation and Persistence of CD8+ Tissue- Resident Memory T Cells  Tessa Bergsbaken, Michael J. Bevan, Pamela J.
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
Engagement of CD1d on ILC3s induces IL‐22 production
IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis
Volume 42, Issue 5, Pages (May 2015)
Volume 20, Issue 3, Pages (July 2017)
Volume 28, Issue 1, Pages (January 2008)
Volume 28, Issue 4, Pages (April 2008)
rSema4A induces iTreg cells in CD4+ T cell cultures.
Volume 33, Issue 1, Pages (July 2010)
Volume 33, Issue 2, Pages (August 2010)
PD‐L1 silencing in antigen presenting DCs results in hyperactivated pro‐inflammatory TCRhigh CD8+ T cells. PD‐L1 silencing in antigen presenting DCs results.
CD160−/− IELs have a defect in granzyme B production during L
Volume 40, Issue 4, Pages (April 2014)
Volume 47, Issue 5, Pages e4 (November 2017)
Volume 34, Issue 4, Pages (April 2011)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Saskia Hemmers, Alexander Y. Rudensky  Cell Reports 
Volume 33, Issue 5, Pages (November 2010)
IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice ARepresentative.
Volume 141, Issue 5, Pages (November 2011)
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
Volume 36, Issue 6, Pages (June 2012)
Volume 38, Issue 6, Pages (June 2013)
Volume 34, Issue 3, Pages (March 2011)
Volume 42, Issue 1, Pages (January 2015)
Volume 43, Issue 1, Pages (July 2015)
Volume 43, Issue 5, Pages (November 2015)
Volume 46, Issue 4, Pages (April 2017)
Volume 33, Issue 5, Pages (November 2010)
Volume 31, Issue 6, Pages (December 2009)
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
Cell-Intrinsic IL-27 and gp130 Cytokine Receptor Signaling Regulates Virus-Specific CD4+ T Cell Responses and Viral Control during Chronic Infection 
Volume 19, Issue 11, Pages (June 2017)
Lipid presentation by CD11c+ cells controls iNKT cell subsets
Volume 126, Issue 6, Pages (September 2006)
P2X4R blockade increases autoimmune inflammation
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 34, Issue 5, Pages (May 2011)
Volume 34, Issue 3, Pages (March 2011)
Volume 41, Issue 2, Pages (August 2014)
Volume 28, Issue 5, Pages (May 2008)
Volume 33, Issue 1, Pages (July 2010)
Macrophage-resident NRP1 mitigates cytokine release and proinflammatory polarization. Macrophage-resident NRP1 mitigates cytokine release and proinflammatory.
Niacin suppresses pro‐inflammatory cytokine expression in macrophages in DSS‐induced colitis in mice Niacin suppresses pro‐inflammatory cytokine expression.
Figure 2 B-cell very late antigen-4 (VLA-4) deficiency reduced CNS accumulation of B cells, but not proinflammatory or regulatory T cells (Treg), in myelin.
Volume 31, Issue 6, Pages (December 2009)
Members of IL-1 family of cytokines favor the generation of IL-3–secreting CD4+ T cells in vitro. Members of IL-1 family of cytokines favor the generation.
Volume 35, Issue 1, Pages (July 2011)
Reduced tumor growth in CCR5-deficient mice is associated with perturbed killing ability of Treg cells. Reduced tumor growth in CCR5-deficient mice is.
CD49b+ cells from tumor-bearing mice are more prone to conversion into MDSCs compared with naive CD49b+ cells. CD49b+ cells from tumor-bearing mice are.
Inhibition of TGF-β signaling abrogates the conversion of glutamine-deprived CD4+ T cells to Treg cells but cannot support TH1 cell generation. Inhibition.
Immunization regimens that include a GLA-SE-formulated protein vaccine generate memory CD4 T cells. Immunization regimens that include a GLA-SE-formulated.
DAC treatment alters immune cell composition and enhances cytokine production in the peritoneal lavage. DAC treatment alters immune cell composition and.
Anti-CD40 activates TAMs and recruits inflammatory monocytes.
The Kinases MEKK2 and MEKK3 Regulate Transforming Growth Factor-β-Mediated Helper T Cell Differentiation  Xing Chang, Fang Liu, Xiaofang Wang, Aiping.
IL35 regulation of tumor growth is accompanied by suppression of CD4+ effector T-cell activity and expansion of Tregs. IL35 regulation of tumor growth.
E2 induces IL-17–producing γδ+ T cells in the FGT
Bb monocolonization enhances Treg population in the cLP.
Presentation transcript:

iNKTcells/CD1d regulate intestinal immunity by controlling Treg induction iNKTcells/CD1d regulate intestinal immunity by controlling Treg induction ARegulatory T cells (Tregs; CD4+Foxp3+) and induced Tregs (iTregs; Nrp1−) in the mLN from CD1d−/− and CD1d+/− mice. Flow cytometry plots (top) and frequency and numbers of Treg and iTreg (bottom) are depicted. Data are from three experiments.B, CC57BL/6 WT mice were orally gavaged with αGalCer, and the Treg populations were analysed 3 days later in mLN (B) and SI‐LP (C). Flow cytometry plots (top) and frequency and numbers of Treg and iTreg (bottom) are depicted. Data are from three independent experiments.D, ECre+ and Cre− CD1dfl/flCD11cCre mice were orally gavaged with αGalCer, and the Treg populations were analysed 3 days later in mLN. Flow cytometry plots (D) and frequency and numbers of iTregs (E) are depicted. Data are from 2–3 experiments.FqPCR analyses for the depicted cytokines in freshly isolated iNKT cells from the mLN of C57BL/6 αGalCer‐treated or control mice. Data are normalized to GAPDH. RE, relative expression. Data are from 3–4 experiments.GqPCR analyses for Tgfb1 in the mLN of CD1d+/+, CD1d−/− or Cre+ CD1dfl/flCD11cCre mice after oral αGalCer administration. Data are from three experiments.H, IC57BL/6 WT mice were orally gavaged with αGalCer ± αIL‐4 or αTGF‐β blocking antibodies, and the Treg population was analysed 3 days later in mLN. Flow cytometry plots (H) and frequency of iTregs (I) are depicted. Data are from three experiments.JSingle‐cell suspensions from the mLN of WT mice were stimulated with PMA/ionomycin for 3 h, and secretion of IFN‐γ and IL‐4 was measured by flow cytometry. Plots show production of IFN‐γ and IL‐4 by mLN cells (left) and αGalCer‐loaded CD1d‐tetramer binding for IL‐4+ (middle) or IFN‐γ+ (right) cells. Data are representative from three experiments.KqPCR analyses for IL4 mRNA in freshly isolated CD11c+ cells, B cells and T cells sort‐purified from the mLN of WT αGalCer‐treated or control mice. Data are normalized to HPRT‐1. RE, relative expression. Data are from four experiments.Data information: Numbers indicate percentage of cells in the indicated gates. Each dot in the bar plots is an individual mouse and bars represent mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, two‐tailed unpaired t‐test. Julia Sáez de Guinoa et al. EMBO J. 2018;37:e97537 © as stated in the article, figure or figure legend